BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation

Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A CIBMTR Prospective Study

(2013) Chris Bredeson et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

High-Dose Methylprednisolone for Veno-Occlusive Disease of the Liver in Pediatric Hematopoietic Stem Cell Transplantation Recipients

(2012) Kasiani C. Myers et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial

(2012) Selim Corbacioglu et al.   LANCET

Predictive Performance of a Busulfan Pharmacokinetic Model in Children and Young Adults

(2012) Imke H. Bartelink et al.   THERAPEUTIC DRUG MONITORING

Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience

(2011) M. A. Slatter et al.   BLOOD

Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases

(2011) Na-Young Shin et al.   EUROPEAN RADIOLOGY

Contribution of fibrinolytic tests to the differential diagnosis of veno-occlusive disease complicating pediatric hematopoietic stem cell transplantation

(2011) Maria Teresa Sartori et al.   PEDIATRIC BLOOD & CANCER

Radiologic Imaging and Intervention for Gastrointestinal and Hepatic Complications of Hematopoietic Stem Cell Transplantation

(2011) Shmuel Y. Mahgerefteh et al.   RADIOLOGY

Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding Trial

(2010) Paul G. Richardson et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation

(2010) L. Marsa-Vila et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome

(2009) Jason A. Coppell et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity

(2009) Cinara L Echart et al.   BLOOD COAGULATION & FIBRINOLYSIS

Absence of VOD in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous Busulphan

(2009) Barbara Cappelli et al.   BRITISH JOURNAL OF HAEMATOLOGY

Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease

(2008) Edward Peres et al.   BLOOD COAGULATION & FIBRINOLYSIS

A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation

(2008) L Barkholt et al.   BONE MARROW TRANSPLANTATION

Vascular disorders of the liver

(2008) Laurie D. DeLeve et al.   HEPATOLOGY